Latest Sickle-cell disease Stories
On Track for Top-Line Data in Q1 2016 SAN DIEGO, April 21, 2015 /PRNewswire/ -- Mast Therapeutics, Inc.
Novel Product Focused On Treatment of Comorbidities of Sickle Cell Disease SOUTH PLAINFIELD, N.J., April 8, 2015 /PRNewswire/ -- Prolong Pharmaceuticals, LLC, a biopharmaceutical company
Rountree Brady Insurance Agency is starting a local charity program in the Savannah, GA area to help a 16-year-old boy currently struggling to keep up with his education due to hospital visits
SAN DIEGO, March 24, 2015 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX), a clinical-stage biopharmaceutical
Researchers at Johns Hopkins have successfully corrected a genetic error in stem cells from patients with sickle cell disease, and then used those cells to grow mature red blood cells, they report. The study represents an important step toward more effectively treating certain patients with sickle cell disease who need frequent blood transfusions and currently have few options.
The Georgia Health Policy Center (GHPC) at Georgia State University has received a five-year, $2,669,903 award from the U.S.
RICHMOND, Calif., Feb. 4, 2015 /PRNewswire/ -- Sangamo BioSciences, Inc.
Reduction in the Frequency of Sickle Cell Crisis, Frequency in Hospitalizations, Hospital Days and Fewer Cases of Acute Chest Syndrome Highlighted in Abstract TORRANCE, Calif., Feb.
LONDON, Jan. 26, 2015 /PRNewswire/ -- About Sickle-cell AnemiaSickle-cell anemia is a disease characterized by the presence of sickle-shaped erythrocytes.
- Preclinical data demonstrating iNKT cell depletion reduces inflammation and improves organ function in a murine model of sickle cell disease WALTHAM, Mass., Dec.
- an ornament or knob in the shape of a flower
- In architecture, a floral ornament; specifically, the large conventional flower usually placed in the center of the abacus of a Corinthian capital or classic ceiling-caisson; also, the floreated termination of a Gothic finial.